2019 J.P. Morgan Healthcare Conference & Silicon Valley Precision Medicine Study Tour – Prospectus Filing
The annual J.P. Morgan Healthcare Conference is regarded as the largest and most information-rich medical investment symposium in the life sciences industry. The 37th J.P. Morgan Healthcare Conference will be held as scheduled in San Francisco on January 7, 2019. The conference will attract tens of thousands of business leaders, emerging companies, technology innovators, and investors, covering the entire global healthcare sector, including pharmaceutical companies, healthcare providers, for-profit and non-profit organizations, and medical device companies.
At this annual flagship event, where industry and capital converge closely, participants will achieve objectives such as product exchange, investment and financing, partnership sourcing, platform leveraging, and project or technology transfer. Together, they will explore future trends in the industry and uncover additional collaboration opportunities.
Information Assembly
The J.P. Morgan Healthcare Conference is the world’s largest and most information-rich investment forum for the pharmaceutical industry. It brings together industry leaders, high-growth companies, and innovative technology startups to share the most cutting-edge technologies and forward-thinking insights in the field.
Investment Conference
The J.P. Morgan Healthcare Conference, also known as the conference for the integration of industry and capital. At that time, top global pharmaceutical companies, financial investment institutions, and investors will flock to attend and make their appearances.
Technical Conference
The conference showcases the latest cutting-edge industry topics, with a particular focus on “biotechnology,” earning it the nickname “Bio Super Bowl.” Licensing and trading of the latest biotechnologies will also be a key agenda item outside the main conference sessions.
Networking Conference
A world-class conference that fosters the cross-pollination and integration of resources from across the globe. Coinciding with the J.P. Morgan Healthcare Conference, professionals from all sectors of the pharmaceutical industry converge in San Francisco. It is an unmissable opportunity for extensive networking among academia, investors, consultants, and CROs.
Exploring development trends and investment directions in the global pharmaceutical and healthcare sectors, and integrating technology and resources worldwide, Health Intelligence Valley, in partnership with the Zhongguancun Meinian Healthcare Industry Research Institute and VCBeat, jointly launches the “J.P. Morgan Summit Study Tour & Health Intelligence Valley International Training Camp.” A distinguished mentor team, including Yu Rong, Chairman of Meinian Onehealth Healthcare Holdings; Ge Li, Chairman of WuXi AppTec; and Professor Tim from the Broad Institute of MIT, will guide entrepreneurs during J.P. Morgan Healthcare Conference Week to expand their horizons, grasp industry trends, build closed-loop business models, and leverage capital empowerment.
Reasonable Schedule, Enhanced Interactivity
This timeStudy Tour Itinerary，1Month7Day —8Day,Covering2Day'sJPMorgan Stanley ConferenceAttend the conference, and based on member circumstances,Carefully SelectedCompanies and investment institutions in matching fields organize one-on-one meetings, you can according toHotspots in R&D and Latest Achievements in This FieldInvestment TrendsTo Conduct an Exploration。
Additionally, it includes3Top-tier investment firms, incubators, research laboratories, and corporate study tours, such as StanfordBioDesignIncubator Visits and Seminars, Visit to Zhongguancun-Silicon Valley Innovation Center, China-US TelemedicineMore HealthInspections, exchanges, etc.
In addition, forStudy Tour and Exchangein the form of, and also avoidsInspecting PartyUnilateral Presentation, Adoptedpannel discussionin the form of one-on-one matchmaking sessions, facilitating more thorough and effective communication.
Abundant Corporate Resources, More Efficient Integration
Technological Innovation: Collaborating with Stanford to explore the world’s most cutting-edge gene-editing technologies and the underlying logic driving technological upgrades in frontier enterprises.
Business Innovation: A visit to Plug and Play, a tech enterprise incubator and accelerator dedicated to helping startup teams achieve rapid growth, as well as field studies at Silicon Valley Qingyuan Venture Capital, the Stanford Biodesign Incubator, and the Zhongguancun-Silicon Valley Innovation Center. The trip included discussions with early-stage startups within these incubators on technological innovation and business innovation.
Management Innovation: Engaged in visits and exchanges with executives from gene sequencing company BioChain, third-generation sequencing leader Pacific Biosciences, and MIT startup EngineBio to explore best practices in the operational management of cutting-edge medical institutions.
PS: This is a tentative itinerary; the actual schedule may be adjusted based on real-time conditions.
★ Eligible Participants:
1. Founders and Co-Founders of Growth-Stage Enterprises
2. Partner, Investment Firm
3. Corporate Executives
★ Number of Recruits: Limited to 5–10 participants
★ Course Start Date: January 5, 2019 – January 11, 2019
★ Duration: 7-day study tour and conference attendance + intensive coaching
★ Course Fee: RMB 85,000 per person, including conference arrangements, airfare, hotel accommodation, transportation, meals, and travel insurance.
★Contact: 15208495425 (Ms. Fang)
★ Scan the QR code to pre-register
